TGFB2 Gene - Transforming Growth Factor Beta 2

Key regulator of cell growth, differentiation, and extracellular matrix production

Gene Information Card

Symbol TGFB2
Full Name Transforming Growth Factor Beta 2
Gene Type protein-coding
Chromosomal Location 1q41
NCBI Gene ID 7042 ncbi.nlm.nih.gov/gene/7042
Ensembl ID ENSG00000192969
UniProt ID P61812
OMIM ID 190220
HGNC ID 11768
Aliases TGF-beta2, LDS4, MFS4, G-TSF, BSC-1 cell growth inhibitor

Description

The TGFB2 gene encodes transforming growth factor beta 2, a member of the TGF-β superfamily of cytokines. This secreted protein regulates cell proliferation, differentiation, migration, and apoptosis. It plays critical roles in embryonic development, wound healing, immune regulation, and extracellular matrix remodeling. Mutations in TGFB2 are associated with Loeys-Dietz syndrome type 4 and Marfan syndrome-like features.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Loeys-Dietz syndrome 4 (LDS4) Loss-of-function mutations in TGFB2 disrupt TGF-β signaling, leading to aortic aneurysms, arterial tortuosity, and skeletal abnormalities. ClinVar, OMIM
Marfan syndrome-like features Heterozygous TGFB2 mutations cause aortic root dilation and skeletal manifestations overlapping with Marfan syndrome. OMIM, NCBI
Cleft palate TGFB2 deficiency impairs palatal fusion during development, contributing to orofacial clefts. OMIM, PubMed
Coronary artery disease TGFB2 polymorphisms are associated with altered TGF-β signaling and increased risk of atherosclerosis. NCBI, ClinVar

Expression Profile

Tissue Expression
Tissue nTPM level
Heart 12.5 Medium
Lung 8.3 Low
Kidney 6.1 Low
Placenta 15.2 Medium
Adipose tissue 9.8 Low
Skeletal muscle 4.2 Low
Cell Line Expression
Cell Line nTPM Notes
HeLa 10.1 Cervical cancer cell line
A549 7.8 Lung carcinoma cell line
HepG2 5.4 Hepatocellular carcinoma cell line
MCF7 6.9 Breast cancer cell line
K562 3.2 Leukemia cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.739C>T (p.Arg247*) Nonsense Rare Loss of function; associated with LDS4
c.1070G>A (p.Arg357His) Missense Rare Impaired TGF-β signaling; Marfan-like phenotype
c.1240_1241del (p.Leu414fs) Frameshift Rare Premature truncation; aortic aneurysm
c.832C>T (p.Arg278Cys) Missense Rare Reduced ligand secretion; LDS4
Mutation functional classification

Loss of Function (LOF)

Most TGFB2 mutations are loss-of-function, reducing protein secretion or signaling activity, leading to haploinsufficiency and altered TGF-β pathway regulation.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported in TGFB2.

Dominant Negative (DN)

Some missense mutations may exert dominant-negative effects by interfering with dimerization or receptor binding.

Pathways

• TGF-beta signaling pathway (KEGG: hsa04350)
• Signaling pathways regulating pluripotency of stem cells (KEGG: hsa04550)
• Hippo signaling pathway (KEGG: hsa04390)
• AGE-RAGE signaling pathway in diabetic complications (KEGG: hsa04933)
• Cytokine-cytokine receptor interaction (KEGG: hsa04060)

Protein Summary

TGFB2 is a 414-amino-acid secreted protein that forms homodimers and binds to TGF-β receptors (TGFBR1 and TGFBR2) to activate SMAD-dependent and SMAD-independent signaling. It is synthesized as a precursor with a signal peptide and a latency-associated peptide (LAP) that remains non-covalently associated with the mature cytokine. Proteolytic cleavage by furin or other convertases releases the active TGFB2 dimer. The protein is highly conserved across species and is essential for cardiac, craniofacial, and skeletal development.

Related Products

Product name Cat.No. Species Gene ID
TGFB2 Knockout HEK293 Cell Line EDJ-KQ17771 Human 7042 Details Get a Quote
TGFB2 Knockout A-549 Cell Line EDJ-KQ19847 Human 7042 Details Get a Quote
TGFB2 Knockout HeLa Cell Line EDJ-KQ19848 Human 7042 Details Get a Quote
TGFB2 Knockout HCT 116 Cell Line EDJ-KQ71602 Human 7042 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
How did you hear about us: